Serina Therapeutics
SER
31 hedge funds and large institutions have $4.46M invested in Serina Therapeutics in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.01% less ownership
Funds ownership: 0.36% → 0.36% (-0.01%)
6% less funds holding
Funds holding: 33 → 31 (-2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
40% less capital invested
Capital invested by funds: $7.48M → $4.46M (-$3.02M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$48.4K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$43.5K |
| 3 |
SWIG
Strategic Wealth Investment Group
Louisville,
Kentucky
|
+$33.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.7K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$116K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$89.5K |
| 3 |
Barclays
London,
United Kingdom
|
-$64K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.35K |
| 5 |
BlackRock
New York
|
-$1.26K |
SER Hedge Fund Activity: Q3 2021 in Review
31 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q3 2021, worth a combined $4.46M — down 40% from $7.48M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SER and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $48.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $116K sold.
- 31 institutional investors held Serina Therapeutics (SER) as of Q3 2021, down from 33 in Q2 2021.
- Funds reported $4.46M of Serina Therapeutics stock for Q3 2021, down 40% quarter-over-quarter.
- 3 funds opened new Serina Therapeutics positions in Q3 2021 and 4 closed out, a net change of -1 holder.
- The largest Serina Therapeutics buyer in Q3 2021 was Citadel Advisors, an estimated $48.4K added.
- The largest Serina Therapeutics seller in Q3 2021 was Renaissance Technologies, an estimated $116K sold.
Based on aggregated 13F filings for Q3 2021.